Platelet-activating factor (PAF)-like oxidized phospholipids: Relevance to atherosclerosis

被引:25
|
作者
Tokumura, A [1 ]
Sumida, T [1 ]
Toujima, M [1 ]
Kogure, K [1 ]
Fukuzawa, K [1 ]
机构
[1] Univ Tokushima, Fac Pharmaceut Sci, Tokushima 7708505, Japan
关键词
platelet-activating factor; oxidized phosphatidylcholine; oxidized low density lipoprotein; atherosclerosis;
D O I
10.1002/biof.5520130106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipid peroxidation is involved in the pathogenesis of chronic diseases including atherosclerosis. Oxidized lipoprotein has diverse biological activities and is believed to initiate atheroma formation and maturate fatty plaque. The active components of oxidized lipoproteins still remain to be clarified, but a likely candidate is the phosphatidylcholine (PC) having an sn-2-short-chain acyl group with a methyl, hydroxyl, aldehydic or carboxylic terminal. These unique PCs, formed by oxidative fragmentation of the polyunsaturated acyl group of the parent PC in liposomes, low density lipoproteins and blood plasma, induce platelet aggregation through the activation of the receptor for platelet-activating factor (PAF), due to their resemblance in structure with PAF. We have found that PAF-like lipids regulate DNA synthesis acid production of nitric oxide independently of the activation of the PAF receptor in vascular smooth muscle cells. Regulation of vascular cell function through two distinct signaling pathways mediated by PAF-like lipids provides new insight into the mechanism of induction of atherosclerosis.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 50 条
  • [21] Platelet-activating factor and lyso-PAF possess direct antimicrobial properties in vitro
    Steel, HC
    Cockeran, R
    Anderson, R
    APMIS, 2002, 110 (02) : 158 - 164
  • [22] Platelet-Activating Factor (PAF) Receptor Antagonism Modulates Inflammatory Signaling in Experimental Uveitis
    Elison, Jasmine R.
    Weinstein, Jessica E.
    Sheets, Kristopher G.
    Regan, Cornelius E., Jr.
    Lentz, Jennifer J.
    Reinoso, Maria
    Gordon, William C.
    Bazan, Nicolas G.
    CURRENT EYE RESEARCH, 2018, 43 (06) : 821 - 827
  • [23] Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)
    Diana M. Stafforini
    Cardiovascular Drugs and Therapy, 2009, 23 : 73 - 83
  • [24] Differential regulation of three catalytic activities of platelet-activating factor (PAF)-dependent transacetylase
    Lee, TC
    Malone, B
    Longobardi, L
    Balestrieri, ML
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 387 (01) : 41 - 46
  • [25] Inhibition of platelet-activating factor (PAF)-induced platelet aggregation by fatty acids from human saliva
    Smal, Mary A.
    Baldo, Brian A.
    PLATELETS, 2022, 33 (04) : 562 - 569
  • [26] Potential Therapeutic Strategies for Severe Anaphylaxis Targeting Platelet-Activating Factor and PAF Acetylhydrolase
    Upton J.
    Vadas P.
    Current Treatment Options in Allergy, 2014, 1 (3) : 232 - 246
  • [27] Platelet-activating factor receptor
    Honda, Z
    Ishii, S
    Shimizu, T
    JOURNAL OF BIOCHEMISTRY, 2002, 131 (06) : 773 - 779
  • [28] Platelet-Activating Factor (PAF): A Review of its Role in Asthma and Clinical Efficacy of PAF Antagonists in the Disease Therapy
    Kasperska-Zajac, Alicja
    Brzoza, Zenon
    Rogala, Barbara
    RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2008, 2 (01) : 72 - 76
  • [29] Inflammation and melanoma growth and metastasis: The role of platelet-activating factor (PAF) and its receptor
    Vladislava Melnikova
    Menashe Bar-Eli
    Cancer and Metastasis Reviews, 2007, 26 : 359 - 371
  • [30] Inflammation and melanoma growth and metastasis: The role of platelet-activating factor (PAF) and its receptor
    Melnikova, Vladislava
    Bar-Eli, Menashe
    CANCER AND METASTASIS REVIEWS, 2007, 26 (3-4) : 359 - 371